Pseudocholinesterase, Dibucaine Inhibition, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Identifying patients who are homozygous for the atypical gene, and have low levels of pseudocholinesterase (PCHE) which are not inhibited by dibucaine
Identifying patients who are heterozygous for the atypical gene, have lower than normal levels of PCHE and varying levels of inhibition with dibucaine
Photometric, Acetylthiocholine Substrate with Dibucaine Addition
Includes pseudocholinesterase, total.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Pseudocholinesterase Dibuc Inhib, S